feed,title,long_url,short_url
Investors,Why Roche's Positive Test Results Sent Olema Pharma Skyrocketing 200%,https://www.investors.com/news/technology/biotech-stock-olema-pharmaceuticals-roche-oral-serd-breast-cancer-treatment/,
Investors,Klarna Revenue Tops Estimates Amid Strong U.S. Growth,https://www.investors.com/news/technology/klarna-stock-klar-klarna-earnings-news-q32025/,
Investors,Medtronic Beelines For A Breakout After Beat-And-Raise Quarter,https://www.investors.com/news/technology/medtronic-stock-medtronic-earnings-q3-2025-2/,
